Yangzi Tian

1.1k total citations · 1 hit paper
28 papers, 785 citations indexed

About

Yangzi Tian is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Gastroenterology. According to data from OpenAlex, Yangzi Tian has authored 28 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 9 papers in Gastroenterology. Recurrent topics in Yangzi Tian's work include Gastrointestinal Tumor Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Gastrointestinal disorders and treatments (6 papers). Yangzi Tian is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Gastrointestinal disorders and treatments (6 papers). Yangzi Tian collaborates with scholars based in China, South Sudan and United States. Yangzi Tian's co-authors include Hongwei Zhang, Man Guo, Daiming Fan, Fan Feng, Xiao Lian, Guanghui Xu, Shushang Liu, Weinan Guo, Gaozan Zheng and Zhen Liu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Cellular and Molecular Life Sciences.

In The Last Decade

Yangzi Tian

27 papers receiving 779 citations

Hit Papers

Diagnostic and prognostic value of CEA, CA19–9, AFP and C... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangzi Tian China 13 361 310 229 187 182 28 785
Wenyi Zhao China 18 231 0.6× 445 1.4× 126 0.6× 337 1.8× 236 1.3× 43 879
Lin Tu China 17 197 0.5× 297 1.0× 93 0.4× 176 0.9× 111 0.6× 38 646
Shinichi Umeda Japan 16 191 0.5× 356 1.1× 122 0.5× 136 0.7× 186 1.0× 58 624
Zhongyin Yang China 14 198 0.5× 318 1.0× 98 0.4× 174 0.9× 152 0.8× 39 612
Yunpeng Liu China 20 454 1.3× 522 1.7× 167 0.7× 354 1.9× 501 2.8× 78 1.3k
Nam-Gyun Kim South Korea 9 151 0.4× 428 1.4× 121 0.5× 305 1.6× 157 0.9× 11 854
Weiming Yue China 17 154 0.4× 394 1.3× 158 0.7× 180 1.0× 192 1.1× 49 812
Akira Kabashima Japan 19 457 1.3× 499 1.6× 415 1.8× 192 1.0× 530 2.9× 53 1.2k
Zaozao Wang China 18 185 0.5× 470 1.5× 75 0.3× 332 1.8× 217 1.2× 48 802
Chih‐Min Tang United States 13 176 0.5× 316 1.0× 147 0.6× 55 0.3× 89 0.5× 18 633

Countries citing papers authored by Yangzi Tian

Since Specialization
Citations

This map shows the geographic impact of Yangzi Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangzi Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangzi Tian more than expected).

Fields of papers citing papers by Yangzi Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangzi Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangzi Tian. The network helps show where Yangzi Tian may publish in the future.

Co-authorship network of co-authors of Yangzi Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Yangzi Tian. A scholar is included among the top collaborators of Yangzi Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangzi Tian. Yangzi Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yi, Xiuli, Sen Guo, Huina Wang, et al.. (2024). SIRT7 promotes mitochondrial biogenesis to render the adaptive resistance to MAPK inhibition in melanoma. Biochemical and Biophysical Research Communications. 722. 150161–150161. 1 indexed citations
2.
Yang, Yuqi, Sijia Wang, Xiang-Xu Wang, et al.. (2024). Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma. Cell Communication and Signaling. 22(1). 83–83. 5 indexed citations
3.
Tian, Yangzi, Jingjing Ma, Meng‐Ru Wang, et al.. (2023). BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY. Experimental Dermatology. 32(10). 1633–1643. 7 indexed citations
4.
Yi, Xiuli, Huina Wang, Yuqi Yang, et al.. (2023). SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation. Signal Transduction and Targeted Therapy. 8(1). 107–107. 28 indexed citations
5.
Tian, Yangzi, Jingjing Ma, Hao Wang, et al.. (2023). BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions. Cellular and Molecular Life Sciences. 80(11). 315–315. 8 indexed citations
6.
Tian, Yangzi, et al.. (2022). Metabolic rewiring directs melanoma immunology. Frontiers in Immunology. 13. 909580–909580. 8 indexed citations
7.
Wang, Huina, Xiuli Yi, Sen Guo, et al.. (2021). The XBP1‒MARCH5‒MFN2 Axis Confers Endoplasmic Reticulum Stress Resistance by Coordinating Mitochondrial Fission and Mitophagy in Melanoma. Journal of Investigative Dermatology. 141(12). 2932–2943.e12. 28 indexed citations
8.
Chen, Jiaxi, Jianru Chen, Yangzi Tian, et al.. (2020). Homocysteine induces melanocytes apoptosis via PERK–eIF2α–CHOP pathway in vitiligo. Clinical Science. 134(10). 1127–1141. 17 indexed citations
10.
Tian, Yangzi & Weinan Guo. (2020). A Review of the Molecular Pathways Involved in Resistance to BRAF Inhibitors in Patients with Advanced-Stage Melanoma. Medical Science Monitor. 26. e920957–e920957. 46 indexed citations
11.
Feng, Fan, Yangzi Tian, Guanghui Xu, et al.. (2017). Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer. BMC Cancer. 17(1). 737–737. 261 indexed citations breakdown →
12.
Feng, Fan, Yangzi Tian, Yuan Zang, et al.. (2017). Low forced vital capacity predicts poor prognosis in gastric cancer patients. Oncotarget. 8(17). 28897–28905. 7 indexed citations
13.
Feng, Fan, Yangzi Tian, Zhen Liu, et al.. (2016). Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor. Medicine. 95(2). e2446–e2446. 21 indexed citations
14.
Feng, Fan, Yangzi Tian, Shushang Liu, et al.. (2016). Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors. Medicine. 95(14). e3248–e3248. 45 indexed citations
16.
Liu, Shushang, Fan Feng, Guanghui Xu, et al.. (2016). Clinicopathological features and prognosis of gastric cancer in young patients. BMC Cancer. 16(1). 478–478. 55 indexed citations
17.
Feng, Fan, Yangzi Tian, Zhen Liu, et al.. (2016). Clinicopathological features and prognosis of omental gastrointestinal stromal tumor: evaluation of a pooled case series. Scientific Reports. 6(1). 30748–30748. 8 indexed citations
18.
Liu, Zhen, Yangzi Tian, Guanghui Xu, et al.. (2016). Pancreatic Gastrointestinal Stromal Tumor. Journal of Clinical Gastroenterology. 51(9). 850–856. 7 indexed citations
19.
Feng, Fan, Yangzi Tian, Zhen Liu, et al.. (2016). Clinicopathological features and prognosis of colonic gastrointestinal stromal tumors: evaluation of a pooled case series. Oncotarget. 7(26). 40735–40745. 12 indexed citations
20.
Feng, Fan, Jianjun Yang, Liping Tong, et al.. (2011). Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells. Cell Biology International. 35(6). 623–629. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026